{"id":"https://openalex.org/W2560465360","doi":"https://doi.org/10.1007/s40273-016-0479-8","title":"Benefits, Challenges and Potential Strategies of Open Source Health Economic Models","display_name":"Benefits, Challenges and Potential Strategies of Open Source Health Economic Models","publication_year":2016,"publication_date":"2016-12-07","ids":{"openalex":"https://openalex.org/W2560465360","doi":"https://doi.org/10.1007/s40273-016-0479-8","mag":"2560465360","pmid":"https://pubmed.ncbi.nlm.nih.gov/27928759","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/5209409"},"language":"en","primary_location":{"id":"doi:10.1007/s40273-016-0479-8","doi":"https://doi.org/10.1007/s40273-016-0479-8","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s40273-016-0479-8","pdf_url":"https://link.springer.com/content/pdf/10.1007/s40273-016-0479-8.pdf","source":{"id":"https://openalex.org/S43019230","display_name":"PharmacoEconomics","issn_l":"1170-7690","issn":["1170-7690","1179-2027"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["abdc-a","anvur-class-a","anvur-scientific","cwts-core","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"PharmacoEconomics","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://link.springer.com/content/pdf/10.1007/s40273-016-0479-8.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5087631426","display_name":"W. Dunlop","orcid":"https://orcid.org/0000-0002-9794-8978","observed_orcids":["https://orcid.org/0000-0002-9794-8978"]},"institutions":[{"id":"https://openalex.org/I4210117898","display_name":"Mundipharma (United Kingdom)","ror":"https://ror.org/025194b42","country_code":"GB","type":"company","lineage":["https://openalex.org/I4210117898"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"William C. N. Dunlop","raw_affiliation_strings":["Mundipharma International Ltd, Cambridge, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mundipharma International Ltd, Cambridge, UK","institution_ids":["https://openalex.org/I4210117898"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042312381","display_name":"Nicola Mason","orcid":"https://orcid.org/0000-0002-8805-8631","observed_orcids":["https://orcid.org/0000-0002-8805-8631"]},"institutions":[{"id":"https://openalex.org/I4210159506","display_name":"BresMed","ror":"https://ror.org/05fd45014","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I4210159506"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"Nicola Mason","raw_affiliation_strings":["BresMed Health Solutions, Sheffield, UK. nmason@bresmed.com","BresMed Health Solutions, Sheffield, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"BresMed Health Solutions, Sheffield, UK. nmason@bresmed.com","institution_ids":["https://openalex.org/I4210159506"]},{"raw_affiliation_string":"BresMed Health Solutions, Sheffield, UK","institution_ids":["https://openalex.org/I4210159506"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109353762","display_name":"James Kenworthy","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210117898","display_name":"Mundipharma (United Kingdom)","ror":"https://ror.org/025194b42","country_code":"GB","type":"company","lineage":["https://openalex.org/I4210117898"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"James Kenworthy","raw_affiliation_strings":["Mundipharma International Ltd, Cambridge, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mundipharma International Ltd, Cambridge, UK","institution_ids":["https://openalex.org/I4210117898"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5010455893","display_name":"Ron L Akehurst","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210159506","display_name":"BresMed","ror":"https://ror.org/05fd45014","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I4210159506"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Ron L. Akehurst","raw_affiliation_strings":["BresMed Health Solutions, Sheffield, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"BresMed Health Solutions, Sheffield, UK","institution_ids":["https://openalex.org/I4210159506"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5042312381"],"corresponding_institution_ids":["https://openalex.org/I4210159506"],"apc_list":{"value":4990,"currency":"USD","value_usd":4990},"apc_paid":{"value":4990,"currency":"USD","value_usd":4990},"fwci":11.656,"has_fulltext":true,"cited_by_count":64,"citation_normalized_percentile":{"value":0.98214213,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":90,"max":100},"biblio":{"volume":"35","issue":"1","first_page":"125","last_page":"128"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.7401999831199646,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},"topics":[{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.7401999831199646,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","score":0.2313999980688095,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T11649","display_name":"Pharmaceutical industry and healthcare","score":0.01080000028014183,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/open-source","display_name":"open source","score":0.7369999885559082},{"id":"https://openalex.org/keywords/health-economic-models","display_name":"health economic models","score":0.9879999756813049},{"id":"https://openalex.org/keywords/pharmaceutical-industry","display_name":"pharmaceutical industry","score":0.7070000171661377},{"id":"https://openalex.org/keywords/transparency","display_name":"transparency","score":0.9300000071525574},{"id":"https://openalex.org/keywords/stakeholder-collaboration","display_name":"stakeholder collaboration","score":0.6650000214576721},{"id":"https://openalex.org/keywords/drug-affordability","display_name":"drug affordability","score":0.6299999952316284},{"id":"https://openalex.org/keywords/access-to-medicines","display_name":"access to medicines","score":0.5910000205039978}],"concepts":[{"id":"https://openalex.org/C524218345","wikidata":"https://www.wikidata.org/wiki/Q31218","display_name":"Health economics","level":3,"score":0.8640265464782715},{"id":"https://openalex.org/C2778091340","wikidata":"https://www.wikidata.org/wiki/Q15749950","display_name":"Quality of Life Research","level":3,"score":0.6905093193054199},{"id":"https://openalex.org/C137992405","wikidata":"https://www.wikidata.org/wiki/Q1137608","display_name":"Health administration","level":3,"score":0.6356104016304016},{"id":"https://openalex.org/C138816342","wikidata":"https://www.wikidata.org/wiki/Q189603","display_name":"Public health","level":2,"score":0.603987455368042},{"id":"https://openalex.org/C144133560","wikidata":"https://www.wikidata.org/wiki/Q4830453","display_name":"Business","level":0,"score":0.4010423421859741},{"id":"https://openalex.org/C100001284","wikidata":"https://www.wikidata.org/wiki/Q2248246","display_name":"Public economics","level":1,"score":0.3709196448326111},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.25958821177482605},{"id":"https://openalex.org/C162324750","wikidata":"https://www.wikidata.org/wiki/Q8134","display_name":"Economics","level":0,"score":0.2493005096912384},{"id":"https://openalex.org/C159110408","wikidata":"https://www.wikidata.org/wiki/Q121176","display_name":"Nursing","level":1,"score":0.12135648727416992}],"mesh":[{"descriptor_ui":"D004470","descriptor_name":"Economics, Medical","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011795","descriptor_name":"Surveys and Questionnaires","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018803","descriptor_name":"Models, Economic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D033181","descriptor_name":"Information Dissemination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":5,"locations":[{"id":"doi:10.1007/s40273-016-0479-8","doi":"https://doi.org/10.1007/s40273-016-0479-8","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s40273-016-0479-8","pdf_url":"https://link.springer.com/content/pdf/10.1007/s40273-016-0479-8.pdf","source":{"id":"https://openalex.org/S43019230","display_name":"PharmacoEconomics","issn_l":"1170-7690","issn":["1170-7690","1179-2027"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["abdc-a","anvur-class-a","anvur-scientific","cwts-core","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"PharmacoEconomics","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:4129914","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/5209409","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:5209409","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/5209409","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacoeconomics","raw_type":"Text"},{"id":"pmid:27928759","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/27928759","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"PharmacoEconomics","raw_type":"Letter"},{"id":"pmh:oai:RePEc:spr:pharme:v:35:y:2017:i:1:d:10.1007_s40273-016-0479-8","doi":null,"is_oa":false,"landing_page_url":"http://link.springer.com/10.1007/s40273-016-0479-8","pdf_url":null,"source":{"id":"https://openalex.org/S4306401271","display_name":"RePEc: Research Papers in Economics","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I77793887","host_organization_name":"Federal Reserve Bank of St. Louis","host_organization_lineage":["https://openalex.org/I77793887"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"article"}],"best_oa_location":{"id":"doi:10.1007/s40273-016-0479-8","doi":"https://doi.org/10.1007/s40273-016-0479-8","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s40273-016-0479-8","pdf_url":"https://link.springer.com/content/pdf/10.1007/s40273-016-0479-8.pdf","source":{"id":"https://openalex.org/S43019230","display_name":"PharmacoEconomics","issn_l":"1170-7690","issn":["1170-7690","1179-2027"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["abdc-a","anvur-class-a","anvur-scientific","cwts-core","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"PharmacoEconomics","raw_type":"journal-article"},"sustainable_development_goals":[],"sustainable_development_goals_aurora":[],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320315078","display_name":"Mundipharma International","ror":null}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2560465360.pdf","grobid_xml":"https://content.openalex.org/works/W2560465360.grobid-xml"},"referenced_works_count":13,"referenced_works":["https://openalex.org/W193479587","https://openalex.org/W1426778341","https://openalex.org/W1587846377","https://openalex.org/W1998789574","https://openalex.org/W2006220335","https://openalex.org/W2007741618","https://openalex.org/W2017677286","https://openalex.org/W2021478579","https://openalex.org/W2134023402","https://openalex.org/W2150712216","https://openalex.org/W2170239385","https://openalex.org/W2461593871","https://openalex.org/W2519603001"],"related_works":["https://openalex.org/W2978107183","https://openalex.org/W2943183194","https://openalex.org/W2540275977","https://openalex.org/W2971447722","https://openalex.org/W2760819862","https://openalex.org/W4239030523","https://openalex.org/W604094774","https://openalex.org/W4220852056","https://openalex.org/W4405751672","https://openalex.org/W2763766138"],"abstract_inverted_index":{"A":[0],"common":[1],"criticism":[2],"of":[3,44,65],"the":[4,22,63],"pharmaceutical":[5],"industry":[6,23],"is":[7,62],"that":[8,56],"it":[9],"fails":[10],"to":[11,25,30,41,60],"achieve":[12],"transparency":[13],"[":[14,47],"1":[15,48],",":[16,49,51],"2":[17],"].":[18,53],"To":[19],"allay":[20],"concerns,":[21],"needs":[24],"collaborate":[26],"openly":[27],"with":[28],"stakeholders":[29],"make":[31],"medicines":[32],"widely":[33],"available":[34],"and":[35],"affordable\u2014this":[36],"will":[37],"mean":[38],"companies":[39],"need":[40],"address":[42,61],"some":[43],"their":[45],"practices":[46],"3":[50],"4":[52],"We":[54],"suggest":[55],"an":[57],"important":[58],"practice":[59],"presentation":[64],"health":[66],"economic":[67],"models.":[68]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":4},{"year":2023,"cited_by_count":6},{"year":2022,"cited_by_count":27},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":9},{"year":2018,"cited_by_count":4},{"year":2017,"cited_by_count":5}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-12-16T00:00:00"}